FRED ALGER MANAGEMENT, LLC
Institutional investor · Portfolio as of Q4 2018
Top Holdings517 positions
MICROSOFT CORP | 15.4M | $1.6B | 7.2% | $94.43 | 0.00% | 1 qtr | First report 0 |
AMAZON COM INC | 1M | $1.5B | 6.9% | $75.10 | 0.00% | 1 qtr | First report 0 |
ALPHABET INC | 935,822 | $969.1M | 4.5% | $51.29 | 0.00% | 1 qtr | First report 0 |
VISA INC | 6.5M | $862.8M | 4.0% | $124.91 | 0.00% | 1 qtr | First report 0 |
UNITEDHEALTH GROUP INC | 3M | $742.4M | 3.4% | $217.84 | 0.00% | 1 qtr | First report 0 |
ADOBE INC | 2.7M | $615M | 2.8% | $226.24 | 0.00% | 1 qtr | First report 0 |
SALESFORCE INC | 4.2M | $580M | 2.7% | $134.64 | 0.00% | 1 qtr | First report 0 |
META PLATFORMS INC | 3.7M | $482.4M | 2.2% | $129.85 | 0.00% | 1 qtr | First report 0 |
BOSTON SCIENTIFIC CORP | 13.2M | $468.2M | 2.2% | $35.34 | 0.00% | 1 qtr | First report 0 |
APPLE INC | 2.9M | $456.9M | 2.1% | $37.39 | 0.00% | 1 qtr | First report 0 |
ABBOTT LABORATORIES | 4.8M | $346.9M | 1.6% | $62.83 | 0.00% | 1 qtr | First report 0 |
ALTABA INC | 5.8M | $333.8M | 1.5% | — | — | 1 qtr | First report 0 |
VERTEX PHARMACEUTICALS INC | 2M | $329.9M | 1.5% | $165.71 | 0.00% | 1 qtr | First report 0 |
Illumina Inc | 1M | $311.5M | 1.4% | $291.76 | 0.00% | 1 qtr | First report 0 |
PAYPAL HLDGS INC | 3.7M | $310M | 1.4% | $83.16 | 0.00% | 1 qtr | First report 0 |
DANAHER CORP DEL | 2.7M | $276.4M | 1.3% | $88.11 | 0.00% | 1 qtr | First report 0 |
HOME DEPOT INC | 1.6M | $272.1M | 1.3% | $141.60 | 0.00% | 1 qtr | First report 0 |
BOEING CO | 819,543 | $264.3M | 1.2% | $307.43 | 0.00% | 1 qtr | First report 0 |
HONEYWELL INTERNATIONAL INC | 1.9M | $256.9M | 1.2% | $111.44 | 0.00% | 1 qtr | First report 0 |
DISNEY WALT CO | 2.3M | $251.5M | 1.2% | $103.57 | 0.00% | 1 qtr | First report 0 |
FRED ALGER MANAGEMENT, LLC manages $21.7B across 517 positions as of Q4 2018. Top holdings: MSFT (7.2%), AMZN (6.9%), GOOG (4.5%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 5/5.0.
First quarter we have for this fund: 517 positions, nothing earlier to compare. No standout high-conviction moves this quarter. Portfolio: $21.7B across 517 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR